Genomic analysis of non-NF2 meningiomas reveals mutations in TRAF7, KLF4, AKT1, and SMO
about
Molecular Genetics of Intracranial Meningiomas with Emphasis on Canonical Wnt SignallingMeningioma Genomics: Diagnostic, Prognostic, and Therapeutic Applications.Ameloblastoma: A Review of Recent Molecular Pathogenetic DiscoveriesNon-Canonical Hh Signaling in Cancer-Current Understanding and Future DirectionsTranscriptomic analysis of aggressive meningiomas identifies PTTG1 and LEPR as prognostic biomarkers independent of WHO grade.Bidirectional interconversion of stem and non-stem cancer cell populations: A reassessment of theoretical models for tumor heterogeneityMolecular pathways: novel approaches for improved therapeutic targeting of Hedgehog signaling in cancer stem cellsFirst insight into the somatic mutation burden of neurofibromatosis type 2-associated grade I and grade II meningiomas: a case report comprehensive genomic study of two cranial meningiomas with vastly different clinical presentation.Whole-genome sequencing identifies new genetic alterations in meningiomasA novel mutation of the FAT2 gene in spinal meningioma.Multiple Meningiomas in a Patient with Cowden Syndrome.Distinguishing grade I meningioma from higher grade meningiomas without biopsy.Smoothened goes molecular: new pieces in the hedgehog signaling puzzleMolecular Testing of Brain Tumor.Genomic profile of human meningioma cell lines.The emerging mutational landscape of G proteins and G-protein-coupled receptors in cancer.Global Proteome and Phospho-proteome Analysis of Merlin-deficient Meningioma and Schwannoma Identifies PDLIM2 as a Novel Therapeutic Target.Follicle-stimulating hormone receptor (FSHR) alternative skipping of exon 2 or 3 affects ovarian response to FSHERK5/KLF4 signaling as a common mediator of the neuroprotective effects of both nerve growth factor and hydrogen peroxide preconditioning.Smoothened gene alterations in keratocystic odontogenic tumors.Somatic and germline CACNA1D calcium channel mutations in aldosterone-producing adenomas and primary aldosteronismIntegrated genomic characterization of IDH1-mutant glioma malignant progressionGlobal expression profile in low grade meningiomas and schwannomas shows upregulation of PDGFD, CDH1 and SLIT2 compared to their healthy tissue.PET Imaging in Patients with Meningioma - Report of the RANO/PET Group.Curcumin acts anti-proliferative and pro-apoptotic in human meningiomas.Genetics of complex traits in psychiatrySporadic hemangioblastomas are characterized by cryptic VHL inactivation.Association between inflammatory infiltrates and isolated monosomy 22/del(22q) in meningiomasNeurosurgery concepts: Key perspectives on dendritic cell vaccines, metastatic tumor treatment, and radiosurgery.Genetic profiling by single-nucleotide polymorphism-based array analysis defines three distinct subtypes of orbital meningiomaPhase II study of monthly pasireotide LAR (SOM230C) for recurrent or progressive meningioma.Protein domain-level landscape of cancer-type-specific somatic mutations.Molecular typing of Meningiomas by Desorption Electrospray Ionization Mass Spectrometry Imaging for Surgical Decision-MakingGroup I Paks as therapeutic targets in NF2-deficient meningioma.Increased expression of the immune modulatory molecule PD-L1 (CD274) in anaplastic meningiomaGenetic/molecular alterations of meningiomas and the signaling pathways targeted.Pathology and molecular genetics of meningioma: recent advances.Differentially Expressed MicroRNAs in Meningiomas Grades I and II Suggest Shared Biomarkers with Malignant Tumors.Somatic POLE mutations cause an ultramutated giant cell high-grade glioma subtype with better prognosis.The Hedgehog pathway: role in cell differentiation, polarity and proliferation
P2860
Q26739662-BEC6B53C-FC55-40DB-BD2D-FF0069C72156Q26741529-2EF54ABD-8C64-443A-A67D-2B50BF2C71B5Q26781648-AF18BABD-9CA3-4EB8-A2DE-2732F8EA6EE4Q26783611-B581B7CB-0C44-48F6-A55A-A45C76A88D06Q27853347-3EBCD010-5D31-4A44-8142-86233860F15BQ28066409-BC837E05-3C54-46F9-91AA-776A87BFF4E4Q28081405-5C1C4564-9A0A-46F6-8EB4-F2A8781461F3Q30274790-1697CD03-1471-4B7F-BC0F-6900C64AC1EFQ30358577-7FF70386-9745-4EE1-A595-2B6555572765Q30369056-8F037602-4C8E-43BB-BBC3-B3E780B0A129Q30375908-BD57D7A3-2000-414B-AD07-8BC88810B8ECQ31006300-4449F466-C6AA-4314-97E0-36340DFC3030Q33359720-E8CCAA5A-7659-4A3B-99DA-5C3E81074BF5Q33729693-013916B7-0AC7-4048-A04C-DC6966FC2B1CQ33731952-981C252A-FFDA-4B9C-8CDA-CB56CA15E686Q33799070-D440F9DC-3E5F-41D9-8D6B-E07851D055C8Q33809716-E3DDA0D7-BD22-4649-8D3E-0D5CE21C7FD8Q33810850-4C310304-B080-4C23-87D0-F0681BD90A3EQ34116124-01EF913C-6FD5-4B94-9549-78BA49C4F720Q34196922-62951A6A-8E0A-44A7-94B3-91145B8EFD64Q34361657-928E13DB-FEF0-471C-A925-0B7E0DA44DE2Q34503475-39D850C8-8E38-485F-BAC3-BBD71BC96D4DQ34556785-EA4EB9B8-E9D4-4437-954A-FC981D5C8C35Q34682187-B9ADD7DC-4AE9-412C-8E06-C517ECC5DBF5Q34716061-FC43A380-BFA0-4293-9280-05B3C15FC4ABQ34803930-BA137FA4-6343-4002-9ABE-4FB108EB5EE4Q34979062-87258E8A-A61E-4835-9902-782CE46C6E3AQ35008994-8314EFB2-FF48-451C-B7E4-596054900900Q35025128-B138DB5B-5E1A-4E25-B25E-998C5CE735B9Q35072568-E4B82D4F-9880-4CF4-92C7-377B620D0E78Q35106253-9B9E6CF7-2E40-429F-BF36-E36A567E6615Q35203134-EF04E4B1-4FE5-4F69-9923-A0CFDB9E957DQ35232689-B74F8D3D-D8D7-4F78-86AE-110D3A33B996Q35273319-AE867999-47F0-4AFD-84D9-7DFCD7438371Q35741539-C63A701F-FD1A-44E8-97E5-EDD224DED2CAQ35793582-5853B67D-ED85-4A70-A9B7-6FA40567EA9CQ35943650-AAB558F7-0CFB-4CFC-990F-00BFAF5D6F99Q35947699-07DB24D6-6339-4EF3-B25F-14D244071D50Q36082471-7BEED9D3-54A5-4B37-8416-D28B0D82D7E5Q36240079-482FBBD1-3864-46AF-AA17-D5A4E998F2B2
P2860
Genomic analysis of non-NF2 meningiomas reveals mutations in TRAF7, KLF4, AKT1, and SMO
description
2013 nî lūn-bûn
@nan
2013 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Genomic analysis of non-NF2 meningiomas reveals mutations in TRAF7, KLF4, AKT1, and SMO
@ast
Genomic analysis of non-NF2 meningiomas reveals mutations in TRAF7, KLF4, AKT1, and SMO
@en
Genomic analysis of non-NF2 meningiomas reveals mutations in TRAF7, KLF4, AKT1, and SMO
@nl
type
label
Genomic analysis of non-NF2 meningiomas reveals mutations in TRAF7, KLF4, AKT1, and SMO
@ast
Genomic analysis of non-NF2 meningiomas reveals mutations in TRAF7, KLF4, AKT1, and SMO
@en
Genomic analysis of non-NF2 meningiomas reveals mutations in TRAF7, KLF4, AKT1, and SMO
@nl
prefLabel
Genomic analysis of non-NF2 meningiomas reveals mutations in TRAF7, KLF4, AKT1, and SMO
@ast
Genomic analysis of non-NF2 meningiomas reveals mutations in TRAF7, KLF4, AKT1, and SMO
@en
Genomic analysis of non-NF2 meningiomas reveals mutations in TRAF7, KLF4, AKT1, and SMO
@nl
P2093
P2860
P50
P356
P1433
P1476
Genomic analysis of non-NF2 meningiomas reveals mutations in TRAF7, KLF4, AKT1, and SMO
@en
P2093
A Fatih Atik
Ahmet Okay Caglayan
Akdes Serin
Alexander Vortmeyer
Bahattin Tanrikulu
Baran Yilmaz
Conor Grady
E Zeynep Erson-Omay
Emre Ceyhun
Eric C Holland
P2860
P304
P356
10.1126/SCIENCE.1233009
P407
P577
2013-01-24T00:00:00Z